Clinical Trials Logo

Smoking Lapse Behavior clinical trials

View clinical trials related to Smoking Lapse Behavior.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00995033 Completed - Smoking Behavior Clinical Trials

Efficacy and Safety of NicVAX® Co-administered With Varenicline (Champix®)

Start date: October 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of NicVAX co-administered with varenicline as an aid in smoking cessation over a one-year period in smokers who want to quit smoking.

NCT ID: NCT00580853 Completed - Clinical trials for Smoking Lapse Behavior

The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior

Start date: April 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to examine how smoking cessation medications (varenicline, bupropion) affect the ability to resist smoking and also subsequent ad-lib smoking in non-treatment seeking daily smokers.